Mlp Saglik Hizmetleri As Class B · BIST:MPARK
Mlp Saglik Hizmetleri As Class B — MLP Care — Q1 2026 Earnings Presentation
19 slides from Mlp Saglik Hizmetleri As Class B's earnings presentation, May 7, 2026
Slide 1: MLPCARE Q1 2026 Presentation
MLPCARE Q1 2026 PRESENTATION M a y 7 th, 2 0 2 6
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care’s future performance and should be considered as good faith estimates made by the Company. These forward-looking statements reflect management expectations and are based upon currently ava
Slide 3: Muharrem Usta, Chairman & CEO
MUHARREM USTA CHAIRMAN & CEO
Slide 4: Q1 2026 Financials at a Glance
Q1 2026 Financials at a Glance • Revenue growth supported by private medical Revenue EBITDA insurance TL 16,252 m TL 4,810 m 6% Growth 25% Growth • EBITDA improvement was driven by favourable revenue mix and ongoing efficiency initiatives • Net debt to EBITDA ratio remained stable Net Debt / Net Pro
Slide 5: Expanding its Network in Türkiye
Expanding its Network in Türkiye 13 City 34 Hospital 5
Slide 6: Slide 6
Slide 7: Revenue is up by 6%
Revenue is up by 6% Revenue (TLm) 5.7% 16.252 15.382 Q1 2025 Q1 2026 Denotes growth of Revenue vs. the same period of the last year 7
Slide 8: Continued Improvement in Average Prices
Continued Improvement in Average Prices Outpatient Revenues (TLm) Inpatient Revenues (TLm) 6.9% 4.4% 6.2% 2.3% 0.7% 2.1% 421 147 167 46 7.219 7.114 7.114 7.261 7.428 6.752 Q1 2025 Volume & Mix Price Q1 2026 Q1 2025 Volume & Mix Price Q1 2026 Average Revenue Per Visit (ARPV) Average Revenue Per Proto
Slide 9: EBITDA is up by 25%
EBITDA is up by 25% EBITDA (TLm)1 24.9% 29.6% 25.0% 4.810 3.853 Q1 2025 Q1 2026 1 EBITDA and EBITDA margin calculated by deducting general administrative expenses from gross profit and adding depreciation and amortization expenses Denotes growth of EBITDA vs. the same period of the last year Denotes
Slide 10: Prudent Cost Management
Prudent Cost Management Cost of Service and G&A Expenses as a % of Revenues Cost Saving Measures enables us to reach the favourable EBITDA Margin EBITDA Margin 25.0% 29.6% 10,4% 9,6% Material costs as a % of revenue decreased by 119bps 2,7% in Q1 2026 driven by effective inventory management 2,4%
Slide 11: Net Income
Net Income Net Profit (TLm) Net Profit (TLm) Equity Holders of the Parent 11.5% 8.9% 1.862 1.668 1.531 1.669 Q1 2025 Q1 2026 Q1 2025 Q1 2026 Denotes growth of Net Profit and Net Profit Allocated to Equity Holders of the Parent vs. the same period of the last year 11
Slide 12: Net Debt Ratio Improves
Net Debt Ratio Improves Leverage Net Debt Net Debt excl. IFRS 16 15,113 6,634 13,159 5,357 0.8x 0.8x 0.4x 0.3x Q1 2025 Q1 2026 Q1 2025 Q1 2026 *All figures are presented in million Turkish Lira 12 Denotes Net Debt / EBITDA multiples
Slide 13: CapEx Focused on Future Expansion
CapEx Focused Leverage on Future Expansion Ratio Improves CapEx decreased by TL 101 million year-on-year in Q1 2026 million TL Q1 2026 Q1 2025 Maintenance: Includes floor openings, Total CapEx 1,769 1,870 renovations and medical equipment purchases in existing hospitals Total CapEx / Revenue 10.
Slide 14: Cash Flow
Cash Flow million TL Q1 2026 Q1 2025 Change EBITDA 4,810 3,853 958 Operating Cash Flow decreased due Changes in working capital (2,331) (377) (1,953) to increased working capital needs, as Tax paid (629) (497) (131) the positive impact of advance Other (1,043) (921) (122) payments in the prior yea
Slide 15: Q&A
Q&A
Slide 16: Closing Remarks
Closing Remarks MUHARREM USTA CHAIRMAN & CEO
Slide 17: Historical Balance Sheet
Historical Balance Sheet Unaudited Audited TLm March 31, 2026 December 31, 2025 Cash and cash equivalents 5,981 8,848 Trade receivables 12,246 10,813 Inventory 1,139 1,222 Short term other assets 2,510 2,696 Current assets 21,875 23,579 Tangible and intangible fixed assets 36,134 35,414 Right of use
Slide 18: Historical P&L Statements
Historical P&L Statements Unaudited Unaudited Change (%) TLm Q1 2026 Q1 2025 Revenues 16,252 15,382 5.7% Cost of service (-) (11,778) (11,152) 5.6% Gross profit 4,473 4,230 5.7% General administration expenses (-) (1,474) (1,410) 4.5% Other income from operations 433 678 (36.1%) Other expenses from
Slide 19: EBITDA Reconciliation
EBITDA Reconciliation TLm Q1 2026 Q1 2025 Change (%) Revenue 16,252 15,382 5.7% Cost of service (11,778) (11,152) 5.6% Gross profit 4,473 4,230 5.7% General administrative expenses (-) (1,474) (1,410) 4.5% Depreciation and amortization expenses (Cost of service) 1,758 977 80.0% Depreciation and amor